| Name | Title | Contact Details |
|---|---|---|
Lisa Burns |
Director of HR Business Partners and | Profile |
Bonnie Ceran |
Senior Director HR, Training and Development | Profile |
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our pipeline consists of small molecule drug candidates that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Our lead drug candidate is tipifarnib, a farnesyl transferase inhibitor, which is currently being studied in multiple Phase 2 clinical trials in solid tumor and hematologic indications. Our pipeline also includes KO-947, an ERK inhibitor, currently in a Phase 1 dose-escalation trial, and KO-539, a menin-MLL inhibitor, currently in preclinical development.
Newlight Technologies is a company based in Irvine, California known for carbon sequestration into plastics.
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.
Biolog is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ReproSource is a Bedford, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.